Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CRVS

Corvus Pharmaceuticals

$11.04

-0.88 (-7.38%)

08:37
06/28/18
06/28
08:37
06/28/18
08:37
Hot Stocks
Corvus announces publication of results of preclinical studies of CPI-444 »

Corvus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CRVS

Corvus Pharmaceuticals

$11.57

-1.57 (-11.95%)

05:48
06/05/18
06/05
05:48
06/05/18
05:48
Initiation
Corvus Pharmaceuticals initiated at Jefferies »

Corvus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRVS

Corvus Pharmaceuticals

$9.38

-0.26 (-2.70%)

16:49
05/03/18
05/03
16:49
05/03/18
16:49
Earnings
Breaking Earnings news story on Corvus Pharmaceuticals »

Corvus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRVS

Corvus Pharmaceuticals

$9.77

-0.19 (-1.91%)

08:39
04/26/18
04/26
08:39
04/26/18
08:39
Hot Stocks
Corvus announces initiation of Phase 1/1b clinical trial of CPI-006 »

Corvus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
CRVS

Corvus Pharmaceuticals

$10.23

-0.09 (-0.87%)

16:50
03/19/18
03/19
16:50
03/19/18
16:50
Hot Stocks
Breaking Hot Stocks news story on Corvus Pharmaceuticals »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRVS

Corvus Pharmaceuticals

$10.54

-0.09 (-0.85%)

16:39
03/14/18
03/14
16:39
03/14/18
16:39
Hot Stocks
Breaking Hot Stocks news story on Corvus Pharmaceuticals »

Orbimed Advisors lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRVS

Corvus Pharmaceuticals

$9.52

0.48 (5.31%)

09:06
03/08/18
03/08
09:06
03/08/18
09:06
Syndicate
Corvus Pharmaceuticals 7.058M share Spot Secondary priced at $8.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

CRVS

Corvus Pharmaceuticals

$9.52

0.48 (5.31%)

16:09
03/07/18
03/07
16:09
03/07/18
16:09
Syndicate
Corvus Pharmaceuticals files to sell $50M in common stock »

Credit Suisse and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRVS

Corvus Pharmaceuticals

$8.55

-0.4 (-4.47%)

, MRK

Merck

$54.14

-0.265 (-0.49%)

13:19
03/06/18
03/06
13:19
03/06/18
13:19
Hot Stocks
Merck trial of preladenant terminated, ClinicalTrials.gov shows »

A Merck (MRK) sponsored…

CRVS

Corvus Pharmaceuticals

$8.55

-0.4 (-4.47%)

MRK

Merck

$54.14

-0.265 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 04

    Apr

  • 23

    Apr

  • 23

    Oct

CRVS

Corvus Pharmaceuticals

$7.82

-0.37 (-4.52%)

16:37
03/01/18
03/01
16:37
03/01/18
16:37
Earnings
Breaking Earnings news story on Corvus Pharmaceuticals »

Corvus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.